Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KC1036 in Advanced Digestive System Tumors
NCT05260385Phase 2Recruiting
- Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Start
- Jan 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of connitinib in digestive system neoplasm, sponsored by Beijing Konruns Pharmaceutical Co., Ltd.. Started Jan 2022; status: recruiting.
02
Drugs
connitinib
03
Conditions
digestive system neoplasm
Beyond the preview
Go deeper on NCT05260385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05260385.